学术探索
学术期刊
新闻热点
数据分析
智能评审

MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE CHEMOTHERAPY FOR OVARIAN MIXED MULLERIAN SARCOMA - REPORT OF 4 CASES

被引：20
作者：
PATSNER, B
GREENBERG, S
机构：
来源：
GYNECOLOGIC ONCOLOGY | 1995年 / 58卷 / 03期
关键词：
D O I：
10.1006/gyno.1995.1248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Four patients with metastatic ovarian mixed Mullerian sarcoma (2 homologous, 2 heterologous) were treated with mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy. Two of four patients had optimal debulking. Three of four patients responded to chemotherapy, with two complete responses of 34- and 46-month duration, The MAID regimen appears to be active in patients with ovarian sarcoma (C) 1995 Academic Press, Inc.
引用
收藏
页码：386 / 388
页数：3
相关论文
共 6 条
[1]   PLATINUM-BASED COMBINATION CHEMOTHERAPY FOR MALIGNANT MIXED MESODERMAL TUMORS OF THE OVARY [J].
ANDERSEN, WA ;
YOUNG, DE ;
PETERS, WA ;
SMITH, EB ;
BAGLEY, CM ;
TAYLOR, PT .
GYNECOLOGIC ONCOLOGY, 1989, 32 (03) :319-322
[2]   RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY [J].
ELIAS, A ;
RYAN, L ;
SULKES, A ;
COLLINS, J ;
AISNER, J ;
ANTMAN, KH .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1208-1216
[3]  
PATSNER B, 1988, CANCER, V62, P1355, DOI 10.1002/1097-0142(19881001)62:7<1355::AID-CNCR2820620719>3.0.CO
[4]  
2-4
[5]   CLINICAL-FEATURES OF ADVANCED OVARIAN MIXED MESODERMAL TUMORS AND TREATMENT WITH DOXORUBICIN-BASED AND CIS-PLATINUM-BASED CHEMOTHERAPY [J].
PLAXE, SC ;
DOTTINO, PR ;
GOODMAN, HM ;
DELIGDISCH, L ;
IDELSON, M ;
COHEN, CJ .
GYNECOLOGIC ONCOLOGY, 1990, 37 (02) :244-249
[6]   COMPLETE RESPONSE OF CARCINOSARCOMA OF THE OVARY TO THERAPY WITH DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE [J].
SIMON, SR ;
WANG, SE ;
UHL, M ;
SHACKNEY, S .
GYNECOLOGIC ONCOLOGY, 1991, 41 (02) :161-166
1